Local tissue distribution and cellular fate of vascular endothelial growth factor (VEGF) following intramuscular injection.

about

Local tissue distribution and cellular fate of vascular endothelial growth factor (VEGF) following intramuscular injection.

Item

http://www.wikidata.org/entity/Q44176141

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Local tissue distribution and ...... owing intramuscular injection.

@en

Local tissue distribution and cellular fate of vascular endothelial growth factor

@nl

type

Item

label

Local tissue distribution and ...... owing intramuscular injection.

@en

Local tissue distribution and cellular fate of vascular endothelial growth factor

@nl

prefLabel

Local tissue distribution and ...... owing intramuscular injection.

@en

Local tissue distribution and cellular fate of vascular endothelial growth factor

@nl

P1476

Local tissue distribution and ...... owing intramuscular injection.

@en

P2093

Ann L Daugherty

http://www.w3.org/2001/XMLSchema#string

Randall J Mrsny

http://www.w3.org/2001/XMLSchema#string

P2860

Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2.

pH regulates vascular endothelial growth factor binding to fibronectin: a mechanism for control of extracellular matrix storage and release

The biology of VEGF and its receptors

Tight junction proteins

KDR (VEGF receptor 2) is the major mediator for the hypotensive effect of VEGF

Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders

Mechanisms of angiogenesis and arteriogenesis

Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism

Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Conne

Clinical applications of angiogenic growth factors and their inhibitors.

P304

27-35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10611860903134317

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19624285

http://www.w3.org/2001/XMLSchema#string

P921

endothelium